nach oben

Intensive Care Medicine

Erschienen in:

01.11.2005 | Editorial

Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate

verfasst von: Jean Chastre

Erschienen in: Intensive Care Medicine | Ausgabe 11/2005

Einloggen, um Zugang zu erhalten

Excerpt

Ventilator-associated pneumonia (VAP) is the most frequent ICU-acquired infection among patients receiving mechanical ventilation (MV) [1, 2]. While controversy continues regarding the mortality due to this process, multiple studies have documented that VAP increases both ICU length of stay and MV duration [1, 3, 4, 5]. VAP also contributes significantly to costs in the ICU. For example, two recent analyses suggest that VAP adds some $40,000 in costs per case [3, 5]. Approximately 50% of antibiotics prescribed in ICUs are administered for respiratory tract infections [6]. …

Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903PubMed

Anonymous (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRefPubMed

Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, Cohen MM, Fraser VJ (2003) Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 31:1312–1317CrossRefPubMed

Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115–2121CrossRefPubMed

Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D (2004) Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 25:1090–1096PubMed

Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, Stobberingh EE (1997) Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 39:527–535CrossRefPubMed

Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122:262–268CrossRefPubMed

Niederman MS (2003) Appropriate use of antimicrobial agents: challenges and strategies for improvement. Crit Care Med 31:608–616CrossRefPubMed

Kollef MH (2003) Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate. Intensive Care Med 29:147–149PubMed

10.

Kollef MH, Ward S, Sherman G, Prentice D, Schaiff R, Huey W, Fraser VJ (2000) Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 28:3456–3464CrossRefPubMed

11.

Giantsou E, Liratzopoulos N, Efraimidou E, Panopoulou M, Alepopoulou E, Kartali-Ktenidou S, Minopoulos GI, Zakynthinos SP, Manolas MI (2005) Both early and late-onset ventilator-associated pneumonia are mainly cause by potentially multiresistant bacteria. Intensive Care Med (s00134-005-2697-4)

12.

Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH (2001) Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29:1109–1115CrossRefPubMed

13.

Rello J, Sa-Borges M, Correa H, Leal SR, Baraibar J (1999) Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 160:608–613PubMed

14.

Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C (1998) Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 157:531–539PubMed

15.

Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R (2004) Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53:1–36

16.

Paterson DL (2004) “Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 38 [Suppl 4]:S341–S345

17.

EORTC International Antimicrobial Therapy Cooperative Group (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 317:1692–1698PubMed

18.

Korvick JA, Bryan CS, Farber B, Beam TR, Schenfeld L, Muder RR, Weinbaum D, Lumish R, Gerding DN, Wagner MM, et al (1992) Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 36:2639–2644PubMed

19.

Paul M, Soares-Weiser K, Leibovici L (2003) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 326:1111CrossRefPubMed

20.

Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, PneumA Trial Group l (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598CrossRefPubMed

21.

Micek ST, Ward S, Fraser VJ, Kollef MH (2004) A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 125:1791–1799CrossRefPubMed

Titel: Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate
verfasst von: Jean Chastre
Publikationsdatum: 01.11.2005
Verlag: Springer-Verlag
Erschienen in: Intensive Care Medicine / Ausgabe 11/2005
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-005-2696-z

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate

Excerpt

Neu im Fachgebiet AINS

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update AINS

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2005

Helium-oxygen decreases inspiratory effort and work of breathing during pressure support in intubated patients with chronic obstructive pulmonary disease

Comparison of two flow generators with a noninvasive ventilator to deliver continuous positive airway pressure: a test lung study

Abdominal compartment syndrome after scuba diving

Pulse oximetry

Acute renal failure and severe neurotoxicity following valacyclovir

Announcements November 2005

Neu im Fachgebiet AINS

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update AINS